Stephen Mayo Allogene Therapeutics, Inc. (ALLO) insider trading activity

ALLO Quotes by TradingView

Stephen Mayo is of Allogene Therapeutics, Inc.. Currently has a direct ownership of 25,328 shares of ALLO, which is worth approximately $55,974. The most recent transaction as insider was on Aug 07, 2023, when has been sold 10,000 shares (Common Stock) at a price of $4.29 per share, resulting in proceeds of $42,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.3K
0% 3M change
0% 12M change
Total Value Held $55,974

Stephen Mayo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 07 2023
SELL
Open market or private sale
$42,900 $4.29 p/Share
10,000 Reduced 28.31%
25,328 Common Stock
Jul 08 2022
BUY
Grant, award, or other acquisition
-
35,328 Added 50.0%
35,328 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
Director
SRPT
Sarepta Therapeutics, Inc. Healthcare
SM

Stephen Mayo

Rahway, NJ

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALLO